Minerva Neurosciences (NERV) Other Non-Current Assets (2013 - 2021)

Minerva Neurosciences posted quarterly Other Non-Current Assets of $14808.0 for Q2 2021, little changed year-on-year from $14808.0 in Q2 2020, and little changed on a QoQ basis from $14808.0 in Q1 2021.

Minerva Neurosciences (NERV) has 7 years of Other Non-Current Assets data on file, last reported at $14808.0 in Q2 2021.

  • For the quarter ending Q2 2021, Other Non-Current Assets changed 0.0% year-over-year to $14808.0; the trailing twelve-month figure through Jun 2021 stood at $14808.0 (changed 0.0% YoY), and the FY2020 full-year result was $14808.0, changed 0.0% from the prior year.
  • Other Non-Current Assets for Q2 2021 stood at $14808.0, roughly flat from $14808.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $14808.0 in Q4 2017 and bottomed at $14808.0 in Q4 2017.
  • The 5-year median for Other Non-Current Assets is $14808.0 (2017), against an average of $14808.0.
  • Peak annual rise in Other Non-Current Assets reached 0.0% in 2018, while the deepest fall reached 0.0% in 2018.
  • A 5-year view of Other Non-Current Assets shows it stood at $14808.0 in 2017, then changed by 0.0% to $14808.0 in 2018, then changed by 0.0% to $14808.0 in 2019, then changed by 0.0% to $14808.0 in 2020, then changed by 0.0% to $14808.0 in 2021.
  • The last three Other Non-Current Assets figures came in at $14808.0 (Q2 2021), $14808.0 (Q1 2021), and $14808.0 (Q4 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 12.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 60,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.26 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.13 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 63.55 Mn
10 Minerva Neurosciences 215.11 Mn 215.11 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2021 14,808.00
Mar 31, 2021 14,808.00
Dec 31, 2020 14,808.00
Sep 30, 2020 14,808.00
Jun 30, 2020 14,808.00
Mar 31, 2020 14,808.00
Dec 31, 2019 14,808.00
Sep 30, 2019 14,808.00
Jun 30, 2019 14,808.00
Mar 31, 2019 14,808.00
Dec 31, 2018 14,808.00
Sep 30, 2018 14,808.00
Jun 30, 2018 14,808.00
Mar 31, 2018 14,808.00
Dec 31, 2017 14,808.00
Jun 30, 2014 3.11 Mn
Dec 31, 2013 433,998.00